lithocholic acid has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balraj, G; Chang, TT; Chen, JY; Cheng, HC; Huang, SM; Juan, HF; Li, WS; Sun, YC; Tang, YA; Wang, SC; Wang, YC; Wu, KW; Wu, LW | 1 |
| Byun, Y; Kim, IS; Kim, SY; Kim, YS; Lee, DY; Lee, GY; Nam, JH; Park, K; Park, RW; Park, SA; Son, DH; Yu, MK | 1 |
2 other study(ies) available for lithocholic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways.
Topics: Animals; Cell Line; Cell Line, Tumor; Focal Adhesion Kinase 1; Humans; Integrins; Lithocholic Acid; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neovascularization, Pathologic; Paxillin; Proteomics; Sialyltransferases; Signal Transduction | 2011 |
Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.
Topics: Angiogenesis Inhibitors; Animals; Anticoagulants; Antineoplastic Agents; Apoptosis; Carrier Proteins; Cell Line, Tumor; Cell Survival; Collagen; Disease Models, Animal; Drug Combinations; Endocytosis; Female; Folate Receptors, GPI-Anchored; Heparin; Humans; Laminin; Lithocholic Acid; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Proteoglycans; Receptors, Cell Surface; Time Factors; Xenograft Model Antitumor Assays | 2007 |